Vietnam: Maximum price of white blood cell products is VND 684.000

According to Article 3 of the Circular No. 17/2020/TT-BYT of the Ministry of Health of Vietnam, maximum price of white blood cell products is specified as follows:

Moreover, Article 3 of the Circular No. 17/2020/TT-BYT also stipulates maximum price of products requiring additional equipment as follows:

Note: The maximum prices stated above are exclusive of the following costs:

- Cost of blood transport from the supplier to the user. In case the supplier carries out the transport itself, transport cost of no more than VND 17.000 shall be added to the price of each blood unit or blood product.

- Cost of testing for abnormal antibodies following the plan provided for in Point a Clause 1 and Point c Clause 4 Article 14 of Circular No. 26/2013/TT-BYT. In case the blood user conducts these tests, a maximum of VND 17.000 shall be added to the price of each whole blood/packed red cell unit of at least 250 ml and each apheresis platelet, apheresis white blood cell or platelet concentrate product;

- Costs of nucleic acid tests conducted following the plan provided for in Point b Clause 1 and Point g Clause 4 Article 14 of Circular No. 26/2013/TT-BYT. In case the blood supplier conducts these tests, a maximum of VND 210.000 shall be added to the price of each whole blood/packed red cell unit of at least 250 ml and each apheresis platelet, apheresis white blood cell or platelet concentrate product;

- Costs of mandatory tests whose conditions are provided for in Points a, b and c Clause 2 and Points c, i and k Clause 4 Article 14 of Circular No. 26/2013/TT-BYT. The blood supplier may conduct these tests when it meets existing regulations on blood transfusion and these tests are indicated by the doctor in charge of the patient;

- Costs of blood type testing, compatibility testing, abnormal antibody determination and identification, bedside blood type testing and equipment used to transfuse the blood unit or blood product to the patient.

View more details at the Circular No. 17/2020/TT-BYT of the Ministry of Health of Vietnam, effective from January 01, 2021.

Le Vy

>> CLICK HERE TO READ THIS ARTICLE IN VIETNAMESE